MedTrace Logo

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates - UK

NCT06869122 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2026-04-21

No results posted yet for this study

Summary

This study involves the use of a medical device, the Creo Medical MicroBlate Flex instrument, to heat and destroy lung tumour cells using microwave energy (this is also called ablation). In this study, the investigators are investigating whether the ablation instrument can be used effectively to treat lung tumours or tumours that have spread to the lungs. If successful, using this technology may mean future patients may not need to undergo surgical removal of these types of lung tumours.

The aim of this study is to evaluate the safety and performance of the MicroBlate Flex instrument in treating individuals with cancerous lung tumours that are due to be removed by surgery. All participants in the study will undergo the microwave ablation procedure, which is a separate and additional procedure to their surgical procedure.

The study, funded by Creo Medical, will be conducted at sites in the UK and Italy, and will involve up to 18 participants.

Conditions

Interventions

DEVICE

Ablation

Bronchoscopy and microwave ablation of the lung tumour prior to surgical resection.

Sponsors & Collaborators

  • Creo Medical Limited

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-14
Primary Completion
2026-11-30
Completion
2026-12-31

Countries

  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06869122 on ClinicalTrials.gov